are glp-1 drugs safe Agonists for Weight Loss: or Risky? FDA warns about unapproved GLP-1
Description
10.2147/NDT.S101925 [DOI] [PMC free article] [PubMed] [Google Scholar] Hill A
This decreases patients appetites and thereby leads to their weight loss

If you have obesity and are considering treatments that can lead to significant weight loss, you may be wondering how the two leading options compare: bariatric surgery, which permanently alters the digestive tract, versus powerful new appetite-suppressing medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
Lengsfeld, Sophia, et al

[DOI] [PubMed] [Google Scholar] 145.Weise WJ, Sivanandy MS, Block CA, Comi RJ

However, it acts in contrast with GLP-1 as much as glucagon release is concerned by enhancing its release
